Juri Alessandro Giannotta, MD

Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
Milano, Lombardia, Italy

Juri Alessandro Giannotta, M.D., Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.
I started my hematology training in 2015 attending the Physiopathology of Anemias Unit directed by Wilma Barcellini in Milan, developing my interests in benign hematology. Later on in 2022 I moved to the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, where I am growing my clinical and research expertise in the treatment of patients with platelet disorders, thrombotic microangiopathies (namely, thrombotic thrombocytopenic purpura) and venous thromboembolism.

Presentation(s):

• OC 26.3 - Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura

  Sunday, June 25, 2023
  15:15 – 15:30 ET

• PB0316 - Bortezomib for the treatment of multi-refractory immune-mediated thrombotic thrombocytopenic purpura: an Italian multicenter survey

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0321 - Prospective evaluation of the HemosIL AcuStar ADAMTS13 Activity Assay

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0333 - Therapeutic Plasma Exchange-Related Complications in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• OC 42.2 - Incidence and Risk Factors of Major Adverse Cardiovascular Events in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura During Remission

  Monday, June 26, 2023
  15:00 – 15:15 ET